Impact of Dose Adaptations Following Voriconazole Therapeutic Drug Monitoring in Pediatric Patients
| dc.contributor.author | Lempers, Vincent J. | |
| dc.contributor.author | Meuwese, Edmé | |
| dc.contributor.author | Mavinkurve-Groothuis, Annelies | |
| dc.contributor.author | Henriet, Stefanie | |
| dc.contributor.author | van der Sluis, Inge M. | |
| dc.contributor.author | Hanff, Lidwien M. | |
| dc.contributor.author | Warris, Adilia | |
| dc.contributor.author | Koch, Birgit C. P. | |
| dc.contributor.author | Brüggemann, Roger J. | |
| dc.contributor.institution | University of Aberdeen.MRC Centre for Medical Mycology | en |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.date.accessioned | 2020-02-13T00:04:47Z | |
| dc.date.available | 2020-02-13T00:04:47Z | |
| dc.date.embargoedUntil | 2020-02-13 | |
| dc.date.issued | 2019-02-13 | |
| dc.description | This manuscript was derived from chapter 9 of the PhD thesis by Vincent Lempers done at Radboudumc, which can be found at: https://repository.ubn.ru.nl/bitstream/handle/2066/157075/157075.pdf?sequence=1 AW is supported by the Wellcome Trust Strategic Award (grant 097377), and the MRC Centre for Medical Mycology (grant MR/N006364/1) at the University of Aberdeen. Funding: this study was funded by the Department of Pharmacy Radboudumc | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 1192604 | |
| dc.identifier | 141628118 | |
| dc.identifier | 8a8c58c5-1587-401e-8e57-1fb192412a83 | |
| dc.identifier | 85072931333 | |
| dc.identifier.citation | Lempers, V J, Meuwese, E, Mavinkurve-Groothuis, A, Henriet, S, van der Sluis, I M, Hanff, L M, Warris, A, Koch, B C P & Brüggemann, R J 2019, 'Impact of Dose Adaptations Following Voriconazole Therapeutic Drug Monitoring in Pediatric Patients', Medical Mycology. https://doi.org/10.1093/mmy/myz006 | en |
| dc.identifier.doi | 10.1093/mmy/myz006 | |
| dc.identifier.issn | 1369-3786 | |
| dc.identifier.other | Mendeley: e05e6040-a6c4-3296-8852-24786c46dc8c | |
| dc.identifier.uri | https://hdl.handle.net/2164/13687 | |
| dc.identifier.url | http://www.mendeley.com/research/impact-dose-adaptations-following-voriconazole-therapeutic-drug-monitoring-pediatric-patients | en |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85072931333&partnerID=8YFLogxK | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Medical Mycology | en |
| dc.subject | voriconazole | en |
| dc.subject | therapeutic drug monitoring | en |
| dc.subject | pediatrics | en |
| dc.subject | azoles | en |
| dc.subject | pharmacokinetics | en |
| dc.subject | RJ Pediatrics | en |
| dc.subject | Wellcome Trust | en |
| dc.subject | 097377 | en |
| dc.subject | Medical Research Council (MRC) | en |
| dc.subject | MR/N006364/1 | en |
| dc.subject.lcc | RJ | en |
| dc.title | Impact of Dose Adaptations Following Voriconazole Therapeutic Drug Monitoring in Pediatric Patients | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
